Literature DB >> 10823143

Muscle changes in the neuroleptic malignant syndrome.

W M Behan1, M Madigan, B J Clark, J Goldberg, D R McLellan.   

Abstract

AIMS: To characterise the skeletal muscle changes in the neuroleptic malignant syndrome (NMS).
METHODS: Detailed light and ultrastructural examination was carried out on skeletal muscle from three cases of NMS, two associated with recreational drugs (3,4-methlenedioxymethylamphetamine (MDMA, Ecstasy) and lysergic acid diethylamide (LSD)) and one with antipsychotic drugs (fluoxetine (Prozac) and remoxipride hydrochloride monohydrate (Roxiam)).
RESULTS: The muscles were grossly swollen and oedematous in all cases, in one with such severe local involvement that the diagnosis of sarcoma was considered. On microscopy, there was conspicuous oedema. In some fascicles less than 10% of fibres were affected whereas in others more than 50% were pale and enlarged. There was a spectrum of changes: tiny to large vacuoles replaced most of the sarcoplasm and were associated with necrosis. A striking feature in some fibres was the presence of contraction bands separating segments of oedematous myofibrils. Severe endomysial oedema was also detectable. There was a scanty mononuclear infiltrate but no evidence of regeneration.
CONCLUSIONS: The muscle changes associated with NMS are characteristic and may be helpful in differential diagnosis.

Entities:  

Mesh:

Year:  2000        PMID: 10823143      PMCID: PMC1731156          DOI: 10.1136/jcp.53.3.223

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  31 in total

1.  Muscle pathology in the neuroleptic malignant syndrome.

Authors:  D T Martin; M Swash
Journal:  J Neurol       Date:  1987-12       Impact factor: 4.849

Review 2.  Malignant hyperthermia myopathy--a critical review.

Authors:  D G Harriman
Journal:  Br J Anaesth       Date:  1988-02       Impact factor: 9.166

3.  Virus-like particles in skeletal muscle of a heat stroke victim.

Authors:  G E Burch; R S Sohal; H L Colcolough; S C Sun
Journal:  Arch Environ Health       Date:  1968-12

Review 4.  Current concepts. Neuroleptic malignant syndrome.

Authors:  B H Guzé; L R Baxter
Journal:  N Engl J Med       Date:  1985-07-18       Impact factor: 91.245

Review 5.  The neuroleptic malignant syndrome, so-called. A survey of the world literature.

Authors:  A M Kellam
Journal:  Br J Psychiatry       Date:  1987-06       Impact factor: 9.319

6.  Neuroleptic malignant syndrome: review and analysis of 115 cases.

Authors:  G Addonizio; V L Susman; S D Roth
Journal:  Biol Psychiatry       Date:  1987-08       Impact factor: 13.382

7.  Multiple severe complications from recreational ingestion of MDMA ('Ecstasy')

Authors:  C Brown; J Osterloh
Journal:  JAMA       Date:  1987-08-14       Impact factor: 56.272

8.  Acute myoglobinuric renal failure. A consequence of the neuroleptic malignant syndrome.

Authors:  A R Eiser; M S Neff; R F Slifkin
Journal:  Arch Intern Med       Date:  1982-03

9.  Neuroleptic malignant syndrome. Patient with unique clinical and physiologic features.

Authors:  G P Downey; M Rosenberg; S Caroff; S Beck; H Rosenberg; J C Gerber; T D Heiman-Patterson; M D Aronson
Journal:  Am J Med       Date:  1984-08       Impact factor: 4.965

10.  'Eve' and 'Ecstasy'. A report of five deaths associated with the use of MDEA and MDMA.

Authors:  G P Dowling; E T McDonough; R O Bost
Journal:  JAMA       Date:  1987-03-27       Impact factor: 56.272

View more
  2 in total

Review 1.  The pharmacology and toxicology of "ecstasy" (MDMA) and related drugs.

Authors:  H Kalant
Journal:  CMAJ       Date:  2001-10-02       Impact factor: 8.262

Review 2.  Sudden adult death.

Authors:  Neil E I Langlois
Journal:  Forensic Sci Med Pathol       Date:  2009-07-18       Impact factor: 2.007

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.